erlotinib hydrochloride has been researched along with Rosacea in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bukvić Mokos, Z; Kovačević, S; Paštar, Z; Pavliša, G; Rezaković, S | 1 |
| Buhren, BA; Gerber, PA; Homey, B; Kukova, G | 1 |
| Aguilar, A; Aspiroz, C; Cuétara, MS; del Palacio, A; Martin, L | 1 |
| Bragg, J; Pomeranz, MK | 1 |
4 other study(ies) available for erlotinib hydrochloride and Rosacea
| Article | Year |
|---|---|
Erlotinib-induced Rosacea-like Dermatitis.
Topics: Aged; Antineoplastic Agents; Drug Eruptions; Erlotinib Hydrochloride; Humans; Male; Rosacea | 2016 |
Density of Demodex folliculorum in patients receiving epidermal growth factor receptor inhibitors.
Topics: Adult; Aged; Animals; Antineoplastic Agents; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Female; Gefitinib; Humans; Male; Middle Aged; Mite Infestations; Mites; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Rosacea; Skin | 2011 |
Erlotinib associated with rosacea-like folliculitis and Malassezia sympodialis.
Topics: Aged; Antineoplastic Agents; Dermatomycoses; Drug Eruptions; Erlotinib Hydrochloride; Folliculitis; Humans; Malassezia; Male; Quinazolines; Rosacea | 2006 |
Papulopustular drug eruption due to an epidermal growth factor receptor inhibitors, erlotinib and cetuximab.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Rectal Neoplasms; Rosacea | 2007 |